简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-09-18 13:12 SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment
2025-09-18 10:16 Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025
2025-09-18 10:06 Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board
2025-09-17 18:12 Andong Jongga Culture Center Targets U.S. Export and Entry into Major Mongolian Retailers
2025-09-17 13:40 Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
2025-09-17 09:45 Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
2025-09-16 16:01 Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody
2025-09-16 10:24 Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas
2025-09-16 10:08 FrieslandCampina Ingredients Expands R&D Capabilities with New State-of-the-Art Application Centre in Singapore
2025-09-15 14:06 Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation
2025-09-12 17:43 René Lammers Appointed Chief Research & Innovation Officer of The Estée Lauder Companies
2025-09-12 10:18 Nominations Open for Fifth Edition of Aster Guardians Global Nursing Award 2026 Worth USD 250,000
2025-09-12 09:28 Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec
2025-09-11 15:15 EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
2025-09-10 16:02 Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
2025-09-10 11:20 France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
2025-09-10 10:40 Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase
2025-09-08 15:07 Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
2025-09-08 11:00 Amazfit T-Rex 3 Pro Smartwatch Launches Featuring a Rugged Titanium Design and Integrated Flashlight
2025-09-08 10:43 U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease

Business Wire Weibo

Press Releases

Latest Releases